The human growth hormone (GH) receptor and its truncated isoform: Sulfhydryl group inactivation in the study of receptor internalization and GH-binding protein generation

Endocrinology

Volumn 140, Issue 1, 1999, Pages 266-272

  Amit, Tamar ^a   Bar Am, Orit ^a   Dastot, Florence ^b   Youdim, Moussa B H ^a   Amselem, Serge ^b   Hochberg, Ze'ev ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HENRI MONDOR HOSPITAL   (France)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DISULFIDE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; IODOACETAMIDE; N ETHYLMALEIMIDE; THIOL GROUP;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0032943869     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6459     Document Type: Article

References (35)

1. 1. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Benzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
2. 2. Fuh G, Mulkerrin MG, Bass S, McFarland N, Brochier M, Bourell JH, Light DR, Wells JA 1990 The human growth hormone receptor. Secretion from Escherichia coli and disulfole bonding pattern of the extracellular binding domain. J Biol Chem 265:3111-3115
3. 3. Barnard R, Waters MJ 1997 The serum growth hormone binding protein: pregnant with possibilities. J Endocrinol 153:1-14
4. 4. Baumann G, Stolar MW, Amburn K, Barasano CP, Devries BC 1986 A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62:134-141
5. 5. Herington AC, Ymer S, Stevenson J 1986 Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77:1817-1823
6. 6. Ymer S, Herington AC 1985 Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol Cell Endocrinol 41:153-163
7. 7. Amit T, Barkey RJ, Bick T, Hertz P, Youdim MBH, Hochberg Z 1990 Identification of growth hormone-binding protein in rat serum. Mol Cell Endocrinol 70:197-202.
8. 8. Smith WC, Kuniyosh J, Talamantes F 1989 Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains. Mol Endocrinol 3:984-990
9. 9. Baumbach WR, Horner DL, Logan JS 1989 The growth hormone-binding protein in rat serum is an alternative spliced form of the growth hormone receptor. Genes Dev 3:1199-1205
10. 10. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J 1993 Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 132:1863-1865
11. 11. Trivedi B, Daughaday WH 1988 Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation. Endocrinology 123:2201-2206
12. 12. Massa G, Ilondo M, Vanderschneren-Lodeweyckx M 1993 Comparison between the human serum growth hormone-binding protein and the water-soluble growth hormone-binding site released from IM-9 lymphocytes. Acta Endocrinol (Copenh) 129:559-564
13. 13. Amit T, Hacham H, Dally O, Barkey RJ, Hochberg Z 1994 The Hep G2 cell line in the study of growth hormone receptor/binding protein. Mol Cell Endocrinol 101:29-36
14. 14. Harrison SM, Barnard R, Ho KY, Rajkovic I, Waters MJ 1995 Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor. Endocrinology 136:651-659
15. 15. Dastot F, Sobrier M-L, Duquesnoy P, Duriez B, Goossens M, Amselem S 1996 Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein. Proc Natl Acad Sci USA 93:10723-10728
16. 16. Ross RJM, Esposito N, Shen XY, Von Lane S, Chew SL, Dobson PRM, Postel-Vinay M-C, Finidori J 1997 A short isoform of the human growth receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 11:265-273
17. 17. Amit T, Bergman T, Dastot F, Youdim MBH, Amselem S, Hochberg Z 1997 A membrane-fixed, truncated isoform of the human growth hormone receptor. J Clin Endocrinol Metab 82:3813-3817
18. 18. Ayling RM, Ross R, Towner P, Von Lane S, Finidori J, Moutonssamy S, Buchanan CR, Clayton PE, Norman MR 1997 A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet 16:13-14
19. 19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265:275
20. 20. Roupas P, Herington AC 1987 Receptor-mediated endocytosis and degradative processing of growth hormone by rat adipocytes in primary culture. Endocrinology 120:215:2158-2165
21. 21. Bick T, Amit T, Manzur M, Bar-Am O, Youdim MBY, Hochberg Z 1996 Regulation of cellular rabbit growth hormone (GH) receptor and GH-binding protein generation in vitro. Endocrinology 147:3977-3985
22. 22. Scatchard G 1949 The interaction of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672
23. 23 Barnard R, Budensen PG, Rylatt DB, Waters MJ 1985 Evidence from the use of monoclonal antibody probes for structural heterogeneity of growth hormone receptor. Biochemistry 231:459-468
24. 24. Amit T, Bick T, Youdim MBH, Hochberg Z 1996 In search of the cellular site of growth hormone (GH)-binding protein cleavage from the rabbit GH receptor. Endocrinology 137:3986-3991
25. 25. Sonne O 1988 Receptor-mediated endocytosis and degradation of insulin. Physiol Rev 68:1129-1195
26. 26. Samanta AK, Dutta S, Ali E 1993 Modification of sulfhydryl groups of interleukin-8 (IL-8) receptor impairs binding of IL-8 and IL-8-mediated chemotactic response of human polymorphonuclear neutrophils. J Biol Chem 268:6147-6153
27. 27. Ilondo MM, Damholt AB, Cunningham BA, Wells JA, De Meyts P, Shymko RM 1944 Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology 134:2397-2403
28. 28. Frank SJ, Gilliland G, Van Epps C 1994 Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor. Endocrinology 135:148-156
29. 29. Hochberg Z, Phillip M, Youdim MBH, Amit T 1993 Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatility. Metabolism 42:1617-1623
30. 30. Eriksson JW, Lonnroth P, Wesslau C, Smith U 1997 Insulin promotes and cyclic adenosine 3',5'-monophosphate impairs functional insertion of insulin receptors in the plasma membrane of rat adipocytes: evidence for opposing effects of tyrosine and serine/threonine phosphorylation. Endocrinology 138:607-612
31. 31. Torossian K, Freedman D, Fantus IG 1988 Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes. J Biol Chem 263:9353-9359
32. 32. Tanaka H, Teitelbaum SL 1990 Vitamin D regulates transferrin receptor expression by bone marrow macrophage precursors. J Cell Physiol 145:303-309
33. 33. Han HM, Kolhatkar AA, Marino MW, Manchester KM, Donner DB 1990 Identification, characterization, and homologous up-regulation of latent (cryptic) receptors for tumor necrosis factor-α in rat liver plasma membranes. J Biol Chem 265:18590-18594
34. 34. Yu ZW, Wickman A, Eriksson JW 1996 Cryptic receptors for insulin-like growth factor II in the plasma membrane of rat adipocytes - a possible link to cellular insulin resistance. Biochim Biophys Acta 1282:57-62
35. 35. Alele J, Jiang J, Goldsmith JF, Yang X, Maheshwari HG, Black RA, Baumann G, Frank SJ 1998 Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. Endocrinology 139:1927-1935